WuXi Chemistry’s Post

Gastroenteropancreatic Neuroendocrine Tumors Market to Showcase a Significant Growth by 2032, Evaluates DelveInsight | Key Players - Eli Lilly and Company, Phanes Therapeutics, Camurus AB, Advanced Accelerator Applications, PharmaMar: The global GEP-NET therapeutics market is further expected to increase by the major drivers such as rising incident population, technological advancements, increased funding for new drug development and clinical trials, increasing awareness among common people, increasing research...

The hotly anticipated 2nd RNA Assay Development & Screening Summit returns to Boston, August 20-22, 2024, to revolutionize RNA-targeted drug discovery with robust assays and screens. Check out the Brand-New Event Guide here: https://ter.li/zuknlg Don’t miss your opportunity to see expert talks with industry leaders from AstraZeneca, Arrakis Therapeutics, Biogen, NextRNA Therapeutics, Accent Therapeutics, Inc. , Atavistik Bio and many more, at the industry's first and only conference dedicated to supporting in-house assay development and screening strategies for discovering selective RNA-targeting small molecules. #RNAtargeting #RNA #smallmolecules #drugdiscovery #assaydevelopment #assay #screening

Catch up on a webinar, the Lumit™ FcRn Binding Immunoassay as a tool in the development of antibody-based therapeutics – Users share their experiences. Viewers will gain an understanding of Lumit™ Immunoassays, their applications, and how they simplify #FcRn binding analysis. https://bit.ly/3uTSIWK

Natural Killer Cells Therapeutics Market Projected to Double to US$ 5.4 Billion by 2028 with Robust CAGR of 13.70%: DUBLIN , Jan. 3, 2024 /PRNewswire/ -- The "Global Natural Killer Cells Therapeutics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering. The global natural killer cells therapeutics market is...

🚀 Kicking off Day 2 of the 20th BioPharma Drug Discovery Nexus Conference with a bang! Join Mauro Mileni Founder and CEO, Abilita Therapeutics, Inc. as he unveils insights into 'Enabling the Discovery of Therapeutic Antibodies Targeting Challenging Membrane Proteins'. Don't miss out on this enlightening session! #BioPharma #DrugDiscovery #Innovation #Antibodies #Therapeutics #Membraneproteins #Epitopes #Conformational #Protiens #NexusConference #SanDiego #USconference #ScientificConference

CAR-T isn't hype anymore. Here are 10 CAR-NK companies you need to know: 1. Artiva Biotherapeutics 2. Dragonfly Therapeutics 3. Fate Therapeutics 4. Glycostem Therapeutics 5. ImmuneBridge 6. ImmunityBio 7. Nkarta 8. NKGen Biotech 9. ONK Therapeutics 10. Senti Biosciences CAR-NK is a technology that could address the shortcomings of CAR-T. Thanks to natural killer cells, this treatment could be a more effective alternative to CAR-T. Clinical trials also show a safer profile, with fewer critical side effects such as cytokine release syndrome. It's definitely an area to watch in #biotech. For more, check the Labiotech.eu article in the comments.

Fibromyalgia Market to Register Incremental Growth During the Forecast Period (2023-2032), Asserts DelveInsight | AppliedVR, Aptinyx, Scilex Holding, Tryp Therapeutics, UCB, Virios Therapeutics, Axsome Therapeutics, Paradise Genomics, Tonix Pharma https://lnkd.in/ezgz92_r #marketanalysis #marketresearch #marketresearchreports #businessintelligence

EEV™ therapeutics consist of two essential parts: an EEV and a therapeutic modality. We’re working to establish a new class of medicines with the potential to reach and engage disease-causing targets within cells. Curious #HowWeEEV? Get the facts: https://lnkd.in/eMs9w2fF. 

Unlock the potential of light scattering techniques in quality control and development processes of mRNA-LNP therapeutics. Join our webinar tomorrow, May 7th, to gain an edge in your research.

EEV™ therapeutics consist of two essential parts: an EEV and a therapeutic modality. We’re working to establish a new class of medicines with the potential to reach and engage disease-causing targets within cells.   Curious #HowWeEEV? Get the facts: https://lnkd.in/dcFuBP5F